AVHNY vs. LLY
AVHNY (Ackermans & Van Haaren NV ADR) and LLY (Eli Lilly and Company) are both stocks. AVHNY operates in Engineering & Construction (Industrials), while LLY operates in Drug Manufacturers - General (Healthcare). Over the past year, AVHNY returned 63.97% vs 44.67% for LLY. At a correlation of -0.04, they often move in opposite directions.
Performance
AVHNY vs. LLY - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, AVHNY achieves a 2.08% return, which is significantly lower than LLY's 3.36% return.
AVHNY
- 1D
- 0.00%
- 1M
- 2.08%
- YTD
- 2.08%
- 6M
- 2.08%
- 1Y
- 63.97%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
LLY
- 1D
- 0.45%
- 1M
- 3.95%
- YTD
- 3.36%
- 6M
- 3.66%
- 1Y
- 44.67%
- 3Y*
- 35.08%
- 5Y*
- 37.87%
- 10Y*
- 33.14%
AVHNY vs. LLY - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | |
|---|---|---|---|
AVHNY Ackermans & Van Haaren NV ADR | 2.08% | 76.45% | 0.00% |
LLY Eli Lilly and Company | 3.36% | 40.25% | -15.09% |
Correlation
The correlation between AVHNY and LLY is -0.07, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | -0.07 |
Correlation (All Time) Calculated using the full available price history since Oct 11, 2024 | -0.04 |
Fundamentals
AVHNY:
$8.61B
LLY:
$991.83B
AVHNY:
€3.21
LLY:
$28.14
AVHNY:
7.21
LLY:
39.34
AVHNY:
0.41
LLY:
0.79
AVHNY:
0.63
LLY:
13.76
AVHNY:
1.33
LLY:
31.79
AVHNY:
€11.98B
LLY:
$72.25B
AVHNY:
€3.73B
LLY:
$59.75B
AVHNY:
€2.52B
LLY:
$32.97B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
AVHNY vs. LLY — Risk / Return Rank
AVHNY
LLY
AVHNY vs. LLY - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Ackermans & Van Haaren NV ADR (AVHNY) and Eli Lilly and Company (LLY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| AVHNY | LLY | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.19 | ||
| Sortino ratioReturn per unit of downside risk | +22.86 | ||
| Omega ratioGain probability vs. loss probability | 25.42 | 1.24 | +24.18 |
| Calmar ratioReturn relative to maximum drawdown | 24.74 | 1.94 | +22.81 |
| Martin ratioReturn relative to average drawdown | 40.85 | 4.84 | +36.01 |
Loading charts...
Drawdowns
AVHNY vs. LLY - Drawdown Comparison
The maximum AVHNY drawdown since its inception was -2.64%, smaller than the maximum LLY drawdown of -68.24%. Use the drawdown chart below to compare losses from any high point for AVHNY and LLY.
Loading charts...
Drawdown Indicators
| AVHNY | LLY | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -2.64% | -68.24% | +65.60% |
Max Drawdown (1Y)Largest decline over 1 year | -2.64% | -23.18% | +20.54% |
Max Drawdown (3Y)Largest decline over 3 years | — | -34.48% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -34.48% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -34.48% | — |
Current DrawdownCurrent decline from peak | 0.00% | -4.64% | +4.64% |
Average DrawdownAverage peak-to-trough decline | -0.74% | -19.20% | +18.46% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 1.59% | 9.26% | -7.67% |
Volatility
AVHNY vs. LLY - Volatility Comparison
The current volatility for Ackermans & Van Haaren NV ADR (AVHNY) is 2.05%, while Eli Lilly and Company (LLY) has a volatility of 8.54%. This indicates that AVHNY experiences smaller price fluctuations and is considered to be less risky than LLY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| AVHNY | LLY | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 2.05% | 8.54% | -6.49% |
Volatility (6M)Calculated over the trailing 6-month period | 2.05% | 26.85% | -24.80% |
Volatility (1Y)Calculated over the trailing 1-year period | 65.47% | 37.83% | +27.64% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 57.75% | 32.45% | +25.30% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 57.75% | 30.20% | +27.55% |
Dividends
AVHNY vs. LLY - Dividend Comparison
AVHNY's dividend yield for the trailing twelve months is around 2.03%, more than LLY's 0.58% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
AVHNY Ackermans & Van Haaren NV ADR | 2.03% | 1.64% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
LLY Eli Lilly and Company | 0.58% | 0.56% | 0.67% | 0.78% | 1.07% | 1.23% | 1.75% | 1.96% | 1.94% | 2.46% | 2.77% | 2.37% |
Financials
AVHNY vs. LLY - Financials Comparison
This section allows you to compare key financial metrics between Ackermans & Van Haaren NV ADR and Eli Lilly and Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
AVHNY vs. LLY - Profitability Comparison
AVHNY - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Ackermans & Van Haaren NV ADR reported a gross profit of 409.06M and revenue of 2.91B. Therefore, the gross margin over that period was 14.1%.
LLY - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Eli Lilly and Company reported a gross profit of 15.64B and revenue of 19.80B. Therefore, the gross margin over that period was 79.0%.
AVHNY - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Ackermans & Van Haaren NV ADR reported an operating income of 379.86M and revenue of 2.91B, resulting in an operating margin of 13.1%.
LLY - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Eli Lilly and Company reported an operating income of 9.19B and revenue of 19.80B, resulting in an operating margin of 46.4%.
AVHNY - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Ackermans & Van Haaren NV ADR reported a net income of 316.94M and revenue of 2.91B, resulting in a net margin of 10.9%.
LLY - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Eli Lilly and Company reported a net income of 7.40B and revenue of 19.80B, resulting in a net margin of 37.4%.
Frequently Asked Questions
AVHNY and LLY have a correlation of -0.07, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
LLY has higher volatility (8.54%) compared to AVHNY (2.05%). In terms of maximum drawdown, AVHNY dropped -2.64% vs LLY's -68.24%.
LLY currently has the higher Sharpe Ratio (1.19 vs 1.00), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for AVHNY and LLY
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer